1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
697723CCEB65C74DD85257E51006C2DB2
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-benchmarking-medical-device-quality-2014-15-noncomforming-activities?opendocument
18
19opendocument
2018.97.14.81
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Quality, Compliance and Regulatory » Assuring Quality Programs

Benchmarking Medical Device Quality 2014-15: Nonconforming Activities

ID: 5365


Features:

4 Info Graphics

30 Data Graphics

450+ Metrics


Pages/Slides: 47


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Benchmarking Medical Device Quality 2014-15: Nonconforming Activities"

STUDY OVERVIEW

Quality leaders in the medical device industry continually have to balance issues of quality and cost. Among the myriad activities associated with the quality function are dealing with nonconforming issues - deviations from standards or specifications.

Best Practices, LLC undertook this study to help quality leaders better understand the role of the the quality function regarding managing/funding key nonconforming activities. The study also addresses the level of Quality nonconforming activities conducted in low-wage markets, CAPA and NCEs ratios, and additional Quality metrics. Research findings provide evidence-based benchmarks around these issues so quality leaders can compare their efforts with industry peers.

This study contains a Large Company Segment (LCS) that is made up of 11 companies.


KEY TOPICS

  • Nonconforming Activities
  • Additional Quality Activities


KEY METRICS
  • Quality role in funding and managing key nonconforming activities
  • Percentage of Quality nonconforming activities conducted at company sites in low-wage markets
  • Percentage of Quality nonconforming activities conducted by third-party outsourcers in low-wage markets
  • Open CAPAs and NCEs per $100M in revenue
  • CAPA cycle times
  • Complaints per $100M in revenue
  • Field actions and field evaluations
  • Quality role in funding and managing other Quality activities (corporate quality administration, M&A due diligence, others)
SAMPLE KEY FINDINGS
  • Responsibilities in Nonconforming QA Activities: A large majority of participating Quality functions both fund and manage the benchmarked nonconforming QA activities. Greatest financial support goes to CAPA, complaint management, complaint investigation and MDR-MDV reporting.

METHODOLOGY
  • Best Practices, LLC designed and deployed a custom benchmarking survey to executives at 21 leading Medical Device companies.  This study has two segments: Total Benchmark Class (TBC) made up of 21 companies and a Large Company Segment (LCS) that is made up of 11 companies.


Industries Profiled:
Medical Device; Pharmaceutical; Health Care


Companies Profiled:
3M Pharmaceuticals; DePuy Synthes; Baxter Healthcare; Atri Cure; Beckman Coulter; BMC Medical; Becton Dickinson; Bio Tek; Boston Scientific; Cook Medical; Covidien; Endologix; Edwards Lifesciences; Helmer Scientific; Ethicon; GE Healthcare; Medtronic; BARD; Haemonetics Corporation; Invacare Corporation; Lake Region Medical

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.